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The risk of superinfection following routine abdominal drainage after major surgery is debated.
Especially in patients with malignant diseases and a compromised host defense, this might be a factor
increasing morbidity and mortality. During a 3-year period (1986-1988) 41 patients operated on for
malignant abdominal conditions received a peritoneal catheter connected to a subcutaneous portal
inserted in order to participate in a trial on postoperative intraperitoneal chemotherapy using 5-
Fluorouracil. No abdominal drains were inserted. In 15 patients, the subcutaneous portal was used for
evacuation of postoperative fluid accumulation within the abdomen. The mean age was 53 (range 41-70)
years. Inserted catheters were used for drainage up to 1.4 days postoperatively. The daily amount of fluid
drained varied from 20 to 2 000 ml with a mean of 610 ml/patient and day. One patient required removal
of the catheter due to infection around the subcutaneous chamber. Otherwise, the catheter system was
not associated with any other complications or complaints. One patient developed a postoperative left
subphrenic abscess drained percutaneously by the guidance of ultrasonography, a complication that
could not be attributed to the catheter system but merely to the major operation per se. An implantable
device for peritoneal access thus also seem useful for drainage of postoperative fluid collection, as
evaluated in this preliminary report.
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INTRODUCTION
Prophylactic drainage following major abdominal surgery has previously been
routinely used. The benefit of routine drainage following major abdominal surgery
has, however, been questioned and drainage as a port of entry for bacteria has been
proposed1. In patients with malignant diseases and a compromised host defense
against infection, a percutaneous drain carries the risk of introducing bacteria
intraabdominally and thereby increasing morbidity and mortality.
Additional methods of treating these abdominal malignancies are sought for.
Intraperitoneal chemotherapy through an implantable system for peritoneal access
has been under trial during recent years. Probably the most experience hitherto
concerns the use of intraperitoneal chemotherapy for ovarian carcinoma,2-5 though
also trials on the value of intraperitoneal 5-Fluorouracil in patients with colorectal
liver metastases6-8 have been performed. The system used has mainly been a
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permant peritoneal dialysis (Tenckhoff) catheter placed intraperitoneally con-
nected with a totally implanted system placed subcutaneously. In the present study,
patients receiving this kind of system for peritoneal access in order to participate in
a postoperative trial on intraperitoneal chemotherapy, had no other abdominal
drains inserted following surgery and thus the implantable peritoneal access system
was also used for postoperative drainage.
PATIENTS AND METHODS
During the period 1986-1988, a total of 41 patients (27 men, 14 women) had
peritoneal catheters connected with a subcutaneous portal (Trava-Port,
Kabi-Baxter, Stockholm, Sweden) inserted in addition to surgery, as the patients
were going to participate in a trial of postoperative intraperitoneal chemotherapy
(using 5-Fluorouracil). Out of these, 15 patients (8 men, 7 women) had the
implantable system for peritoneal access used for drainage of postoperative fluid
accumulations, as no other abdominal drains were used. The mean age in this
group was 57 (range 41-70) years. The surgical procedures performed were liver
resection (n 6), pancreatectomy (n 4) or preparation for temporary liver
dearterialization with application of a vascular occluding device around the hepatic
artery (n 5). In the remaining 26 patients, 8 had an additional "conventional"
abdominal drainage (PenroseR) inserted, while in the other 18 patients the implan-
table device was not used for drainage of abdominal fluid as the peroperative
surgical trauma was less extensive and the postoperative course was uneventful, not
necessitating the need for drainage. The percutaneous injection portal, consisting
of a conical, stainless steel chamber with a self-sealing silicone rubber septum
connected with a silicone catheter was placed laterally to the left or right border of
the rectus abdominis muscle at, or slightly above, the level of the umbilicus, and
brought through a subcutaneous channel before entering the abdominal cavity. The
system is simply filled with saline but is otherwise without maintenance require-
ments.
RESULTS
Fifteen out of the total of 41 patients (37%) had the peritoneal access system used
for the evacuation of postoperative fluid accumulations. In these cases, the inserted
catheters were used for drainage up to 14 days postoperatively. The mean daily
amount of drained fluid per patients was 610 ml with a range from 20 to 2 000 ml.
The fluid that was drained was in general clear and uninfected. The subcutaneous
portal and catheter system seemed in general to be well tolerated and complications
were few. One patient had the catheter removed due to a local infection around the
subcutaneous port. One patient developed a subphrenic abscess drained percuta-
neously with the guidance of ultrasonography, a complication that was not
contributed to by the catheter system per se, but merely to the major operation
performed.
Among the remaining 26 patients, 3 abdominal abscesses were diagnosed in the
postoperative period, 2 managed percutaneously and 1 surgically. No correlation
between the use of conventional drainage and abscess formation could be seen in
this small series.
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DISCUSSION
Intraperitoneal administration of cytostatic agents, for example, using the des-
cribed system is simple, without a need for an indwelling arterial catheter and
infusion pump. The system provides a more uniform delivery to the hepatic
parenchyma and it achieves the highest plasma levels in the portal system. It can
also be used for treating concomitant intraabdominal disease, which may benefit
from intraperitoneal therapy. The exact indications for using this route of adminis-
tering cytostatic agents, however, remain to be defined.
Implantable ports allow flow rates up to 37 ml/minute with 1 meter of gravity
pressure9. This permits instillation of 2 litres of fluid in approximately 60 minutes
and drainage of the same volume in 60-90 minutes. Furthermore, evacuation can
be enhanced if the needle is attached to a vacuum system. By flushing the catheter,
plugging of the lumen with fibrinous debris does not seem to be a problem and as
the need for evacuation of fluid accumulation in the postoperative period is fairly
limited in time, i.e. drainage is generally needed only for the first postoperative
days, the walling off of the catheter within the peritoneal cavity does not seem to
constitute a major problem. Furthermore, before initiating intraperitoneal drug
administration at our institution, an abdominal scintigraphy using intraperitoneal
TC99m sulphur colloid is performed in order to guarantee a normal intraabdominal
spread.
By using the implanted system for peritonealaccess, there is also the possibility
for postoperative evacuation of fluid from within the abdominal cavity following
major surgery, as is shown in the present study. Thereby, the risk of superinfection
by introducing bacteria through an open abdominal drainage system in these
compromised patients is diminished. Maybe any drainage of abdominal fluid at all
could have been omitted in a few patients in the present series, but drainage
volumes were in general large, probably necessitating some kind of abdominal
drainage in the early postoperative period. Further on, the mobilization of patients
is facilitated by the absence of external drainage, thereby hopefully decreasing the
incidence of postoperative complications and reducing the length of the hospital
stay.
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